2018
DOI: 10.1128/mcb.00107-17
|View full text |Cite
|
Sign up to set email alerts
|

Ligand-Dependent Corepressor (LCoR) Is a Rexinoid-Inhibited Peroxisome Proliferator-Activated Receptor γ–Retinoid X Receptor α Coactivator

Abstract: The nuclear receptor peroxisome proliferator-activated receptor gamma (PPARγ) is an essential regulator of placental development. To gain deeper insights into placental PPARγ signaling, we dissected its regulation of the promoter. We find that, unlike prototypic target activation by heterodimeric receptors, which is either stimulated by or refractory to retinoid X receptor (RXR) ligands (rexinoids), the induction of by liganded PPARγ requires RXRα but is inhibited by rexinoids. We demonstrate that this inhibit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 10 publications
(4 citation statements)
references
References 47 publications
(73 reference statements)
0
4
0
Order By: Relevance
“…Another interesting candidate is LCOR , which is upregulated in the AF+AVB model and encodes a transcriptional cofactor that interacts with PPARγ and RXRα to control gene expression. 38 While further experiments are needed to determine the extent by which LCOR modifies gene expression in AF+AVB and contributes to the pathology, our RNA-seq experiments detected the dysregulation of 2 of its likely targets based on the literature: CPT1A (see above) and the cell cycle regulator CDKN1A. 39 …”
Section: Discussionmentioning
confidence: 97%
“…Another interesting candidate is LCOR , which is upregulated in the AF+AVB model and encodes a transcriptional cofactor that interacts with PPARγ and RXRα to control gene expression. 38 While further experiments are needed to determine the extent by which LCOR modifies gene expression in AF+AVB and contributes to the pathology, our RNA-seq experiments detected the dysregulation of 2 of its likely targets based on the literature: CPT1A (see above) and the cell cycle regulator CDKN1A. 39 …”
Section: Discussionmentioning
confidence: 97%
“…On the other hand, NFKBIA is an inhibitor of the dimerization of transcription factors p50 and RELA in the canonical pathway [ 20 , 41 ]. Additionally, IFRD2 [ 42 ], LCOR [ 43 , 44 ], LRRC33 [ 45 ], NLK [ 46 ], PGRN [ 47 ], SIGLEC11 [ 48 ], and TRAF1 [ 49 ] have suppressive effects on canonical NFκB signaling. The expression of these genes was significantly upregulated in transitional carriers ( Table 3 ).…”
Section: Resultsmentioning
confidence: 99%
“…3B). Another interesting candidate is LCOR, which is up-regulated in the AF+AVB model and encodes a transcriptional cofactor that interacts with PPARγ and RXRα to control gene expression 38 . While further experiments are needed to determine the extent by which LCOR modifies gene expression in AF+AVB and contributes to the pathology, our RNA-seq experiments detected the dysregulation of two of its likely targets based on the literature: CPT1A (see above) and the cell cycle regulator CDKN1A 39 .…”
Section: Molecular Remodeling In Af With Versus Without Avbmentioning
confidence: 99%